FBInvestor
Stocks / Chemocentryx Inc
Institutional Ownership

Chemocentryx Inc

CUSIP 16383L106COMCCXIEURQ1 2026

13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

24 filings · latest Sep 12, 2022

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Sep 12, 2022Fmr LLC13G/A0.0%SEC
2Feb 14, 2022Schall Thomas J.13G/A6.5%4.53MSEC
3Feb 14, 2022Ra Capital Management, L.P.13G/ASEC
4Feb 9, 2022Vanguard Group Inc13G/A7.3%5.10MSEC
5Feb 9, 2022Fmr LLC13G/A15.0%SEC
6Feb 3, 2022Blackrock Inc.13G/A6.2%4.33MSEC
7Oct 14, 2021Vifor (International) Ltd13D/A2.7%1.86MSEC
8Jun 9, 2021Wellington Management Group LLP13G/A0.7%482.7KSEC
9Feb 16, 2021Schall Thomas J.13G/A6.3%4.34MSEC
10Feb 16, 2021Ra Capital Management, L.P.13G/A6.9%4.78MSEC

14 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Chemocentryx Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Huntington National Bank1$52